Arkolith/Insider Trading/FRTX/Form 4

Exploration Capital, LLC

10% OwnerFresh Tracks Therapeutics, Inc. (FRTX) · full profile →Form 4 · filed Mar 21, 2024
Net Buying
Open-Market Buys
$270
Open-Market Sells
$0
Net Open-Market Flow
$270
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 20, 2024Buy(P)287$0.91$261964K
Mar 19, 2024Buy(P)10$0.90$9964K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-024839) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML